$100M sweet spot round size
Most of their 56 investments are in rounds between $40M and $165M
1986
Beta Bionics raised $100M on August 30, 2023
Investors: Sands Capital Management, Pura Vida Investments, Perceptive Advisors, Marshall Wace, RTW Investments, LP, Soleus Capital Management, L.P., Eventide Asset Management, LifeSci Venture Partners, Omega Funds and Farallon Capital Management
MediciNova, Inc. raised $25M on August 1, 2023
Investors: Perceptive Advisors, - and Farallon Capital Management
Auna raised $505M on March 29, 2023
Investors: Lumia Capital, Enfoca and Farallon Capital Management
FogPharma raised $178M on November 21, 2022
Investors: T. Rowe Price, GV, The Invus Group, venBio Partners and Farallon Capital Management
GreenYellow raised $124M on February 21, 2022
Investors: Farallon Capital Management
Beta Bionics raised $57M on February 17, 2022
Investors: Soleus Capital Management, L.P., Pura Vida Investments, Novo Nordisk Ltd, LifeSci Venture Partners, Eventide Asset Management, RTW Investments, LP, Perceptive Advisors and Farallon Capital Management
Ada Health raised $30M on February 10, 2022
Investors: Red River West, Bertelsmann SE & Co. KGaA and Farallon Capital Management
Better Therapeutics raised $70M on October 29, 2021
Investors: Sectoral Asset Management, Monashee Investment Management LLC and Farallon Capital Management
DNA Script raised $165M on October 26, 2021
Investors: Illumina Ventures, Columbia Threadneedle Investments EMEA APAC, M Ventures, EQT Life Sciences, Coatue Management and Farallon Capital Management
InBrace raised $102M on September 8, 2021
Investors: Marshall Wace, Endeavour Vision, Vivo Capital, venBio Partners, MVM Partners, Soleus Capital Management, L.P., RTW Investments, LP and Farallon Capital Management